GW
AMAG

Glenn Welling’s AMAG Pharmaceuticals AMAG Stock Holding History

Glenn Welling’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-50,174
Closed -$1.2M – 15
2016
Q2 		$1.2M Sell
50,174
-15,742
-24% -$361K 0.42% 11
2016
Q1 		$1.54M Buy
65,916
+4,491
+7% +$107K 0.52% 12
2015
Q4 		$1.85M Buy
+61,425
New +$1.98M 1.15% 11

Other funds holding AMAG

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SIM
Stelliam Investment Management New York $404M AUM 5.1% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Glenn Welling's AMAG Position: Q3 2016 in Review

Glenn Welling sold out of AMAG Pharmaceuticals (AMAG) in Q3 2016, closing a stake of 50,174 shares — an estimated $1.2M sold.

Glenn Welling first reported a position in AMAG in Q4 2015 and held it in 3 quarters. The position peaked at $1.85M in Q4 2015. 178 funds tracked by Wall St. Rank hold AMAG as of Q3 2016.

  • Glenn Welling reported no remaining AMAG Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Glenn Welling sold 50,174 AMAG Pharmaceuticals shares in Q3 2016, an estimated $1.2M.
  • Glenn Welling first reported a position in AMAG Pharmaceuticals in Q4 2015 and held it in 3 quarters.
  • Glenn Welling's AMAG Pharmaceuticals position peaked at $1.85M in Q4 2015.
  • 178 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2016.

Based on Engaged Capital's 13F filing for Q3 2016, filed 14 Nov 2016.